Publicaciones (13) Publicaciones de José Manuel Paz González

2023

  1. Risk of Cognitive Impairment in Patients With Parkinson’s Disease With Visual Hallucinations and Subjective Cognitive Complaints

    Journal of Clinical Neurology (Korea), Vol. 19, Núm. 4, pp. 344-357

2022

  1. Constipation Predicts Cognitive Decline in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group

    Journal of Parkinson's Disease, Vol. 12, Núm. 1, pp. 315-331

  2. Isolated speech-induced lingual dystonia successfully treated with botulinum neurotoxin

    Neurologia

  3. Safinamide improves sleep and daytime sleepiness in Parkinson’s disease: results from the SAFINONMOTOR study

    Neurological Sciences, Vol. 43, Núm. 4, pp. 2537-2544

  4. Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson’s Disease Patients with Major Depression: An Open-Label Prospective Study

    Brain Sciences, Vol. 12, Núm. 11

2021

  1. Effectiveness of Safinamide over Mood in Parkinson’s Disease Patients: Secondary Analysis of the Open-label Study SAFINONMOTOR

    Advances in Therapy, Vol. 38, Núm. 10, pp. 5398-5411

  2. Predictors of clinically significant quality of life impairment in Parkinson’s disease

    npj Parkinson's Disease, Vol. 7, Núm. 1

2020

  1. Impact of Coronavirus Disease 2019 Pandemic on Parkinson's Disease: A Cross-Sectional Survey of 568 Spanish Patients

    Movement Disorders, Vol. 35, Núm. 10, pp. 1712-1716

  2. Non-motor symptom burden in patients with Parkinson’s disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort

    Scientific Reports, Vol. 10, Núm. 1

  3. Quality of life and non-motor symptoms in Parkinson's disease patients with subthreshold depression

    Journal of the Neurological Sciences, Vol. 418

  4. The impact of freezing of gait on functional dependency in Parkinson’s disease with regard to motor phenotype

    Neurological Sciences, Vol. 41, Núm. 10, pp. 2883-2892

2019

  1. High ultrasensitive serum C-reactive protein may be related to freezing of gait in Parkinson’s disease patients

    Journal of Neural Transmission, Vol. 126, Núm. 12, pp. 1599-1608

2008

  1. A retrospective study of the effectiveness of lamotrigine in monotherapy for the treatment of epileptic seizures. The ERELMO study

    Revista de Neurologia, Vol. 46, Núm. 4, pp. 197-202